nodes	percent_of_prediction	percent_of_DWPC	metapath
Desogestrel—ESR1—urinary bladder cancer	0.843	1	CbGaD
Desogestrel—SHBG—prostate gland—urinary bladder cancer	0.0027	0.116	CbGeAlD
Desogestrel—Breast cancer—Gemcitabine—urinary bladder cancer	0.00267	0.0415	CcSEcCtD
Desogestrel—PGR—prostate gland—urinary bladder cancer	0.00243	0.104	CbGeAlD
Desogestrel—ESR1—prostate gland—urinary bladder cancer	0.0019	0.0817	CbGeAlD
Desogestrel—PGR—epithelium—urinary bladder cancer	0.00179	0.0768	CbGeAlD
Desogestrel—PGR—Validated nuclear estrogen receptor alpha network—HDAC4—urinary bladder cancer	0.00175	0.0284	CbGpPWpGaD
Desogestrel—PGR—smooth muscle tissue—urinary bladder cancer	0.00172	0.074	CbGeAlD
Desogestrel—ESR1—Signaling events mediated by HDAC Class II—HDAC4—urinary bladder cancer	0.00156	0.0252	CbGpPWpGaD
Desogestrel—PGR—Nuclear signaling by ERBB4—RBX1—urinary bladder cancer	0.00149	0.0242	CbGpPWpGaD
Desogestrel—PGR—Ovarian Infertility Genes—ESR2—urinary bladder cancer	0.00148	0.0239	CbGpPWpGaD
Desogestrel—SHBG—female reproductive system—urinary bladder cancer	0.00147	0.0633	CbGeAlD
Desogestrel—ESR1—epithelium—urinary bladder cancer	0.0014	0.06	CbGeAlD
Desogestrel—Quinestrol—ESR1—urinary bladder cancer	0.00139	0.178	CrCbGaD
Desogestrel—ESR1—smooth muscle tissue—urinary bladder cancer	0.00135	0.0579	CbGeAlD
Desogestrel—SHBG—vagina—urinary bladder cancer	0.00133	0.0573	CbGeAlD
Desogestrel—PGR—female reproductive system—urinary bladder cancer	0.00133	0.057	CbGeAlD
Desogestrel—SHBG—Nongenotropic Androgen signaling—SRC—urinary bladder cancer	0.00131	0.0213	CbGpPWpGaD
Desogestrel—ESR1—renal system—urinary bladder cancer	0.0013	0.0557	CbGeAlD
Desogestrel—PGR—Nuclear Receptors—ESR2—urinary bladder cancer	0.00129	0.0209	CbGpPWpGaD
Desogestrel—Cataract—Thiotepa—urinary bladder cancer	0.00122	0.0189	CcSEcCtD
Desogestrel—PGR—vagina—urinary bladder cancer	0.0012	0.0516	CbGeAlD
Desogestrel—PGR—Ovarian Infertility Genes—NCOR1—urinary bladder cancer	0.00114	0.0185	CbGpPWpGaD
Desogestrel—Fluid retention—Thiotepa—urinary bladder cancer	0.0011	0.0171	CcSEcCtD
Desogestrel—PGR—Nuclear signaling by ERBB4—S100B—urinary bladder cancer	0.00108	0.0175	CbGpPWpGaD
Desogestrel—Allylestrenol—ESR1—urinary bladder cancer	0.00108	0.139	CrCbGaD
Desogestrel—Erythema nodosum—Epirubicin—urinary bladder cancer	0.00108	0.0168	CcSEcCtD
Desogestrel—Mestranol—ESR1—urinary bladder cancer	0.00105	0.135	CrCbGaD
Desogestrel—ESR1—FOXM1 transcription factor network—XRCC1—urinary bladder cancer	0.00104	0.0169	CbGpPWpGaD
Desogestrel—ESR1—female reproductive system—urinary bladder cancer	0.00104	0.0446	CbGeAlD
Desogestrel—ESR1—Validated nuclear estrogen receptor alpha network—HDAC4—urinary bladder cancer	0.00103	0.0166	CbGpPWpGaD
Desogestrel—Alopecia—Mitomycin—urinary bladder cancer	0.00102	0.0159	CcSEcCtD
Desogestrel—PGR—Nuclear Receptor transcription pathway—ESR2—urinary bladder cancer	0.00102	0.0165	CbGpPWpGaD
Desogestrel—Erythema nodosum—Doxorubicin—urinary bladder cancer	0.000999	0.0155	CcSEcCtD
Desogestrel—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.000977	0.0152	CcSEcCtD
Desogestrel—Norgestimate—ESR1—urinary bladder cancer	0.000974	0.125	CrCbGaD
Desogestrel—PGR—Nuclear signaling by ERBB4—NCOR1—urinary bladder cancer	0.000973	0.0158	CbGpPWpGaD
Desogestrel—Abdominal pain—Valrubicin—urinary bladder cancer	0.000944	0.0147	CcSEcCtD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—PHB—urinary bladder cancer	0.000943	0.0153	CbGpPWpGaD
Desogestrel—ESR1—vagina—urinary bladder cancer	0.000939	0.0403	CbGeAlD
Desogestrel—Fluid retention—Gemcitabine—urinary bladder cancer	0.000926	0.0144	CcSEcCtD
Desogestrel—SHBG—Nongenotropic Androgen signaling—HRAS—urinary bladder cancer	0.000923	0.015	CbGpPWpGaD
Desogestrel—PGR—Ovarian Infertility Genes—ATM—urinary bladder cancer	0.000903	0.0146	CbGpPWpGaD
Desogestrel—PGR—Ovarian Infertility Genes—CDK4—urinary bladder cancer	0.000899	0.0146	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—MT2A—urinary bladder cancer	0.000899	0.0146	CbGpPWpGaD
Desogestrel—ESR1—Nuclear signaling by ERBB4—RBX1—urinary bladder cancer	0.000876	0.0142	CbGpPWpGaD
Desogestrel—Hypertension—Mitomycin—urinary bladder cancer	0.00087	0.0135	CcSEcCtD
Desogestrel—Fluid retention—Cisplatin—urinary bladder cancer	0.000863	0.0134	CcSEcCtD
Desogestrel—PGR—Validated nuclear estrogen receptor alpha network—ESR2—urinary bladder cancer	0.000848	0.0137	CbGpPWpGaD
Desogestrel—Etonogestrel—ESR1—urinary bladder cancer	0.000843	0.108	CrCbGaD
Desogestrel—Vaginal discharge—Methotrexate—urinary bladder cancer	0.00082	0.0127	CcSEcCtD
Desogestrel—Diarrhoea—Valrubicin—urinary bladder cancer	0.000817	0.0127	CcSEcCtD
Desogestrel—Ethinyl Estradiol—ESR2—urinary bladder cancer	0.000816	0.105	CrCbGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—HPGDS—urinary bladder cancer	0.00081	0.0131	CbGpPWpGaD
Desogestrel—PGR—Nuclear Receptors—ESR1—urinary bladder cancer	0.000781	0.0126	CbGpPWpGaD
Desogestrel—PGR—lymph node—urinary bladder cancer	0.000776	0.0334	CbGeAlD
Desogestrel—Vaginal discharge—Epirubicin—urinary bladder cancer	0.000768	0.0119	CcSEcCtD
Desogestrel—PGR—Nuclear signaling by ERBB4—ESR1—urinary bladder cancer	0.000764	0.0124	CbGpPWpGaD
Desogestrel—ESR1—LKB1 signaling events—TSC1—urinary bladder cancer	0.000762	0.0124	CbGpPWpGaD
Desogestrel—Vomiting—Valrubicin—urinary bladder cancer	0.000759	0.0118	CcSEcCtD
Desogestrel—ESR1—Nuclear Receptors—ESR2—urinary bladder cancer	0.000755	0.0122	CbGpPWpGaD
Desogestrel—Rash—Valrubicin—urinary bladder cancer	0.000753	0.0117	CcSEcCtD
Desogestrel—Dermatitis—Valrubicin—urinary bladder cancer	0.000752	0.0117	CcSEcCtD
Desogestrel—Headache—Valrubicin—urinary bladder cancer	0.000748	0.0116	CcSEcCtD
Desogestrel—PGR—Nuclear Receptors—PPARG—urinary bladder cancer	0.000712	0.0115	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—ESR2—urinary bladder cancer	0.000711	0.0115	CbGpPWpGaD
Desogestrel—Vaginal discharge—Doxorubicin—urinary bladder cancer	0.00071	0.011	CcSEcCtD
Desogestrel—Nausea—Valrubicin—urinary bladder cancer	0.000709	0.011	CcSEcCtD
Desogestrel—Weight increased—Thiotepa—urinary bladder cancer	0.000662	0.0103	CcSEcCtD
Desogestrel—PGR—Validated nuclear estrogen receptor alpha network—NCOR1—urinary bladder cancer	0.000655	0.0106	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.000653	0.0106	CbGpPWpGaD
Desogestrel—ESR1—Nuclear signaling by ERBB4—S100B—urinary bladder cancer	0.000635	0.0103	CbGpPWpGaD
Desogestrel—PGR—Nuclear Receptor transcription pathway—ESR1—urinary bladder cancer	0.000617	0.01	CbGpPWpGaD
Desogestrel—ESR1—lymph node—urinary bladder cancer	0.000607	0.0261	CbGeAlD
Desogestrel—ESR1—Nuclear Receptor transcription pathway—ESR2—urinary bladder cancer	0.000597	0.00967	CbGpPWpGaD
Desogestrel—Breast disorder—Cisplatin—urinary bladder cancer	0.000597	0.00926	CcSEcCtD
Desogestrel—Levonorgestrel—ESR1—urinary bladder cancer	0.000596	0.0764	CrCbGaD
Desogestrel—PGR—Cellular roles of Anthrax toxin—TNF—urinary bladder cancer	0.000586	0.00949	CbGpPWpGaD
Desogestrel—ESR1—Nuclear signaling by ERBB4—NCOR1—urinary bladder cancer	0.000571	0.00926	CbGpPWpGaD
Desogestrel—Diarrhoea—Mitomycin—urinary bladder cancer	0.000563	0.00874	CcSEcCtD
Desogestrel—PGR—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.000563	0.00912	CbGpPWpGaD
Desogestrel—ESR1—FOXM1 transcription factor network—CCNE1—urinary bladder cancer	0.000554	0.00899	CbGpPWpGaD
Desogestrel—Eye disorder—Thiotepa—urinary bladder cancer	0.000544	0.00845	CcSEcCtD
Desogestrel—Danazol—ESR1—urinary bladder cancer	0.000543	0.0696	CrCbGaD
Desogestrel—Breast pain—Epirubicin—urinary bladder cancer	0.000535	0.00831	CcSEcCtD
Desogestrel—Immune system disorder—Thiotepa—urinary bladder cancer	0.000526	0.00816	CcSEcCtD
Desogestrel—Vomiting—Mitomycin—urinary bladder cancer	0.000523	0.00812	CcSEcCtD
Desogestrel—Rash—Mitomycin—urinary bladder cancer	0.000519	0.00805	CcSEcCtD
Desogestrel—Dermatitis—Mitomycin—urinary bladder cancer	0.000518	0.00804	CcSEcCtD
Desogestrel—Headache—Mitomycin—urinary bladder cancer	0.000515	0.008	CcSEcCtD
Desogestrel—Alopecia—Thiotepa—urinary bladder cancer	0.000515	0.00799	CcSEcCtD
Desogestrel—PGR—Validated nuclear estrogen receptor alpha network—ESR1—urinary bladder cancer	0.000514	0.00834	CbGpPWpGaD
Desogestrel—Mental disorder—Thiotepa—urinary bladder cancer	0.00051	0.00792	CcSEcCtD
Desogestrel—Malnutrition—Thiotepa—urinary bladder cancer	0.000507	0.00787	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—RBX1—urinary bladder cancer	0.000503	0.00815	CbGpPWpGaD
Desogestrel—Ethinyl Estradiol—ESR1—urinary bladder cancer	0.000502	0.0644	CrCbGaD
Desogestrel—ESR1—Validated nuclear estrogen receptor alpha network—ESR2—urinary bladder cancer	0.000498	0.00807	CbGpPWpGaD
Desogestrel—Breast pain—Doxorubicin—urinary bladder cancer	0.000495	0.00769	CcSEcCtD
Desogestrel—Nausea—Mitomycin—urinary bladder cancer	0.000489	0.00758	CcSEcCtD
Desogestrel—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.000463	0.00719	CcSEcCtD
Desogestrel—Neoplasm—Methotrexate—urinary bladder cancer	0.000451	0.007	CcSEcCtD
Desogestrel—Fluid retention—Epirubicin—urinary bladder cancer	0.000443	0.00688	CcSEcCtD
Desogestrel—Immune system disorder—Gemcitabine—urinary bladder cancer	0.000443	0.00687	CcSEcCtD
Desogestrel—Hypertension—Thiotepa—urinary bladder cancer	0.000438	0.00679	CcSEcCtD
Desogestrel—Alopecia—Gemcitabine—urinary bladder cancer	0.000433	0.00672	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.000429	0.00665	CcSEcCtD
Desogestrel—Eye disorder—Cisplatin—urinary bladder cancer	0.000427	0.00662	CcSEcCtD
Desogestrel—Alopecia—Fluorouracil—urinary bladder cancer	0.000426	0.00661	CcSEcCtD
Desogestrel—ESR1—FOXM1 transcription factor network—CDK4—urinary bladder cancer	0.000425	0.00688	CbGpPWpGaD
Desogestrel—Neoplasm—Epirubicin—urinary bladder cancer	0.000422	0.00655	CcSEcCtD
Desogestrel—ESR1—Nuclear Receptors—PPARG—urinary bladder cancer	0.000418	0.00677	CbGpPWpGaD
Desogestrel—Immune system disorder—Cisplatin—urinary bladder cancer	0.000412	0.0064	CcSEcCtD
Desogestrel—Fluid retention—Doxorubicin—urinary bladder cancer	0.00041	0.00637	CcSEcCtD
Desogestrel—Nervous system disorder—Thiotepa—urinary bladder cancer	0.000406	0.0063	CcSEcCtD
Desogestrel—Alopecia—Cisplatin—urinary bladder cancer	0.000404	0.00626	CcSEcCtD
Desogestrel—Skin disorder—Thiotepa—urinary bladder cancer	0.000402	0.00624	CcSEcCtD
Desogestrel—Malnutrition—Cisplatin—urinary bladder cancer	0.000398	0.00617	CcSEcCtD
Desogestrel—Erythema multiforme—Etoposide—urinary bladder cancer	0.000396	0.00614	CcSEcCtD
Desogestrel—Eye disorder—Etoposide—urinary bladder cancer	0.000391	0.00607	CcSEcCtD
Desogestrel—Neoplasm—Doxorubicin—urinary bladder cancer	0.000391	0.00606	CcSEcCtD
Desogestrel—ESR1—Validated nuclear estrogen receptor alpha network—NCOR1—urinary bladder cancer	0.000384	0.00623	CbGpPWpGaD
Desogestrel—Immune system disorder—Etoposide—urinary bladder cancer	0.000378	0.00586	CcSEcCtD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—IGF1—urinary bladder cancer	0.000373	0.00605	CbGpPWpGaD
Desogestrel—ESR1—FOXM1 transcription factor network—CREBBP—urinary bladder cancer	0.000371	0.00601	CbGpPWpGaD
Desogestrel—Alopecia—Etoposide—urinary bladder cancer	0.00037	0.00574	CcSEcCtD
Desogestrel—ESR1—FOXM1 transcription factor network—RB1—urinary bladder cancer	0.000369	0.00598	CbGpPWpGaD
Desogestrel—Hypertension—Gemcitabine—urinary bladder cancer	0.000368	0.00571	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—S100B—urinary bladder cancer	0.000365	0.00591	CbGpPWpGaD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.000361	0.0056	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000357	0.00554	CcSEcCtD
Desogestrel—ESR1—FOXA1 transcription factor network—CREBBP—urinary bladder cancer	0.000357	0.00579	CbGpPWpGaD
Desogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—urinary bladder cancer	0.000351	0.00569	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000343	0.00556	CbGpPWpGaD
Desogestrel—Mood swings—Methotrexate—urinary bladder cancer	0.000343	0.00532	CcSEcCtD
Desogestrel—ESR1—ATF-2 transcription factor network—PLAU—urinary bladder cancer	0.000342	0.00555	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—RHOA—urinary bladder cancer	0.000342	0.00554	CbGpPWpGaD
Desogestrel—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000341	0.0053	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.00034	0.00551	CbGpPWpGaD
Desogestrel—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000338	0.00525	CcSEcCtD
Desogestrel—Skin disorder—Gemcitabine—urinary bladder cancer	0.000338	0.00525	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000336	0.00522	CcSEcCtD
Desogestrel—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000336	0.00521	CcSEcCtD
Desogestrel—Migraine—Epirubicin—urinary bladder cancer	0.000334	0.00518	CcSEcCtD
Desogestrel—Affect lability—Epirubicin—urinary bladder cancer	0.000334	0.00518	CcSEcCtD
Desogestrel—PGR—Validated nuclear estrogen receptor alpha network—CCND1—urinary bladder cancer	0.000334	0.00541	CbGpPWpGaD
Desogestrel—ESR1—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.00033	0.00535	CbGpPWpGaD
Desogestrel—Urticaria—Thiotepa—urinary bladder cancer	0.000329	0.0051	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—NCOR1—urinary bladder cancer	0.000328	0.00531	CbGpPWpGaD
Desogestrel—Breast disorder—Methotrexate—urinary bladder cancer	0.000327	0.00508	CcSEcCtD
Desogestrel—Abdominal pain—Thiotepa—urinary bladder cancer	0.000327	0.00508	CcSEcCtD
Desogestrel—ESR1—FOXM1 transcription factor network—CDKN2A—urinary bladder cancer	0.000325	0.00526	CbGpPWpGaD
Desogestrel—ESR1—ATF-2 transcription factor network—CDK4—urinary bladder cancer	0.000324	0.00524	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—TERT—urinary bladder cancer	0.000323	0.00523	CbGpPWpGaD
Desogestrel—Mood swings—Epirubicin—urinary bladder cancer	0.000321	0.00498	CcSEcCtD
Desogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—NCOR1—urinary bladder cancer	0.000318	0.00516	CbGpPWpGaD
Desogestrel—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000318	0.00494	CcSEcCtD
Desogestrel—Skin disorder—Cisplatin—urinary bladder cancer	0.000315	0.00489	CcSEcCtD
Desogestrel—Hypertension—Etoposide—urinary bladder cancer	0.000314	0.00488	CcSEcCtD
Desogestrel—Migraine—Doxorubicin—urinary bladder cancer	0.000309	0.00479	CcSEcCtD
Desogestrel—Affect lability—Doxorubicin—urinary bladder cancer	0.000309	0.00479	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000308	0.00478	CcSEcCtD
Desogestrel—PGR—Validated nuclear estrogen receptor alpha network—EP300—urinary bladder cancer	0.000307	0.00498	CbGpPWpGaD
Desogestrel—Breast disorder—Epirubicin—urinary bladder cancer	0.000306	0.00475	CcSEcCtD
Desogestrel—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000305	0.00473	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000301	0.00466	CcSEcCtD
Desogestrel—ESR1—AP-1 transcription factor network—PLAU—urinary bladder cancer	0.000299	0.00484	CbGpPWpGaD
Desogestrel—Mood swings—Doxorubicin—urinary bladder cancer	0.000297	0.00461	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000295	0.00459	CcSEcCtD
Desogestrel—ESR1—Signaling by ERBB4—RBX1—urinary bladder cancer	0.000295	0.00478	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—ATM—urinary bladder cancer	0.00029	0.0047	CbGpPWpGaD
Desogestrel—Skin disorder—Etoposide—urinary bladder cancer	0.000289	0.00448	CcSEcCtD
Desogestrel—Breast disorder—Doxorubicin—urinary bladder cancer	0.000283	0.0044	CcSEcCtD
Desogestrel—Diarrhoea—Thiotepa—urinary bladder cancer	0.000283	0.00439	CcSEcCtD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000282	0.00457	CbGpPWpGaD
Desogestrel—ESR1—ATF-2 transcription factor network—RB1—urinary bladder cancer	0.000281	0.00456	CbGpPWpGaD
Desogestrel—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00028	0.00435	CcSEcCtD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—TSC1—urinary bladder cancer	0.000279	0.00452	CbGpPWpGaD
Desogestrel—ESR1—FOXM1 transcription factor network—CCND1—urinary bladder cancer	0.000274	0.00444	CbGpPWpGaD
Desogestrel—Urticaria—Fluorouracil—urinary bladder cancer	0.000272	0.00422	CcSEcCtD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—MMP9—urinary bladder cancer	0.000271	0.0044	CbGpPWpGaD
Desogestrel—PGR—Validated nuclear estrogen receptor alpha network—MYC—urinary bladder cancer	0.000268	0.00434	CbGpPWpGaD
Desogestrel—Weight increased—Epirubicin—urinary bladder cancer	0.000267	0.00414	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—FGFR3—urinary bladder cancer	0.000265	0.0043	CbGpPWpGaD
Desogestrel—Weight decreased—Epirubicin—urinary bladder cancer	0.000265	0.00411	CcSEcCtD
Desogestrel—Vomiting—Thiotepa—urinary bladder cancer	0.000263	0.00408	CcSEcCtD
Desogestrel—Rash—Thiotepa—urinary bladder cancer	0.000261	0.00405	CcSEcCtD
Desogestrel—Dermatitis—Thiotepa—urinary bladder cancer	0.000261	0.00404	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000259	0.0042	CbGpPWpGaD
Desogestrel—Headache—Thiotepa—urinary bladder cancer	0.000259	0.00402	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000258	0.00418	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—ESR1—urinary bladder cancer	0.000257	0.00417	CbGpPWpGaD
Desogestrel—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000257	0.00398	CcSEcCtD
Desogestrel—ESR1—FOXM1 transcription factor network—EP300—urinary bladder cancer	0.000252	0.00409	CbGpPWpGaD
Desogestrel—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000252	0.00391	CcSEcCtD
Desogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—urinary bladder cancer	0.000251	0.00407	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—SRC—urinary bladder cancer	0.00025	0.00405	CbGpPWpGaD
Desogestrel—Weight increased—Doxorubicin—urinary bladder cancer	0.000247	0.00383	CcSEcCtD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000247	0.004	CbGpPWpGaD
Desogestrel—Nausea—Thiotepa—urinary bladder cancer	0.000246	0.00381	CcSEcCtD
Desogestrel—Weight decreased—Doxorubicin—urinary bladder cancer	0.000245	0.00381	CcSEcCtD
Desogestrel—ESR1—FOXA1 transcription factor network—EP300—urinary bladder cancer	0.000243	0.00394	CbGpPWpGaD
Desogestrel—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000243	0.00377	CcSEcCtD
Desogestrel—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000239	0.00371	CcSEcCtD
Desogestrel—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000238	0.0037	CcSEcCtD
Desogestrel—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000237	0.00368	CcSEcCtD
Desogestrel—Urticaria—Etoposide—urinary bladder cancer	0.000236	0.00366	CcSEcCtD
Desogestrel—Abdominal pain—Etoposide—urinary bladder cancer	0.000235	0.00365	CcSEcCtD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000235	0.0038	CbGpPWpGaD
Desogestrel—Eye disorder—Methotrexate—urinary bladder cancer	0.000234	0.00363	CcSEcCtD
Desogestrel—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000234	0.00363	CcSEcCtD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000228	0.0037	CbGpPWpGaD
Desogestrel—Immune system disorder—Methotrexate—urinary bladder cancer	0.000226	0.00351	CcSEcCtD
Desogestrel—ESR1—ATF-2 transcription factor network—CXCL8—urinary bladder cancer	0.000224	0.00363	CbGpPWpGaD
Desogestrel—Diarrhoea—Cisplatin—urinary bladder cancer	0.000222	0.00344	CcSEcCtD
Desogestrel—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000222	0.00344	CcSEcCtD
Desogestrel—Alopecia—Methotrexate—urinary bladder cancer	0.000221	0.00344	CcSEcCtD
Desogestrel—Vomiting—Gemcitabine—urinary bladder cancer	0.000221	0.00343	CcSEcCtD
Desogestrel—ESR1—FOXM1 transcription factor network—MYC—urinary bladder cancer	0.00022	0.00356	CbGpPWpGaD
Desogestrel—Mental disorder—Methotrexate—urinary bladder cancer	0.00022	0.00341	CcSEcCtD
Desogestrel—Rash—Gemcitabine—urinary bladder cancer	0.000219	0.00341	CcSEcCtD
Desogestrel—Dermatitis—Gemcitabine—urinary bladder cancer	0.000219	0.0034	CcSEcCtD
Desogestrel—Eye disorder—Epirubicin—urinary bladder cancer	0.000219	0.0034	CcSEcCtD
Desogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CREBBP—urinary bladder cancer	0.000219	0.00355	CbGpPWpGaD
Desogestrel—Hypersensitivity—Etoposide—urinary bladder cancer	0.000219	0.0034	CcSEcCtD
Desogestrel—Malnutrition—Methotrexate—urinary bladder cancer	0.000218	0.00339	CcSEcCtD
Desogestrel—Headache—Gemcitabine—urinary bladder cancer	0.000218	0.00338	CcSEcCtD
Desogestrel—Vomiting—Fluorouracil—urinary bladder cancer	0.000218	0.00338	CcSEcCtD
Desogestrel—ESR1—LKB1 signaling events—MYC—urinary bladder cancer	0.000216	0.0035	CbGpPWpGaD
Desogestrel—Rash—Fluorouracil—urinary bladder cancer	0.000216	0.00335	CcSEcCtD
Desogestrel—ESR1—AP-1 transcription factor network—CDKN2A—urinary bladder cancer	0.000216	0.0035	CbGpPWpGaD
Desogestrel—Dermatitis—Fluorouracil—urinary bladder cancer	0.000216	0.00335	CcSEcCtD
Desogestrel—Headache—Fluorouracil—urinary bladder cancer	0.000214	0.00333	CcSEcCtD
Desogestrel—ESR1—Signaling by ERBB4—S100B—urinary bladder cancer	0.000214	0.00347	CbGpPWpGaD
Desogestrel—Immune system disorder—Epirubicin—urinary bladder cancer	0.000212	0.00329	CcSEcCtD
Desogestrel—ESR1—Leptin signaling pathway—RHOA—urinary bladder cancer	0.000211	0.00342	CbGpPWpGaD
Desogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—urinary bladder cancer	0.000209	0.00339	CbGpPWpGaD
Desogestrel—ESR1—ATF-2 transcription factor network—CCND1—urinary bladder cancer	0.000209	0.00339	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000208	0.00336	CbGpPWpGaD
Desogestrel—Alopecia—Epirubicin—urinary bladder cancer	0.000207	0.00322	CcSEcCtD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—KRAS—urinary bladder cancer	0.000207	0.00336	CbGpPWpGaD
Desogestrel—Nausea—Gemcitabine—urinary bladder cancer	0.000207	0.00321	CcSEcCtD
Desogestrel—Vomiting—Cisplatin—urinary bladder cancer	0.000206	0.0032	CcSEcCtD
Desogestrel—Mental disorder—Epirubicin—urinary bladder cancer	0.000205	0.00319	CcSEcCtD
Desogestrel—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000205	0.00318	CcSEcCtD
Desogestrel—Rash—Cisplatin—urinary bladder cancer	0.000205	0.00317	CcSEcCtD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000204	0.00331	CbGpPWpGaD
Desogestrel—Dermatitis—Cisplatin—urinary bladder cancer	0.000204	0.00317	CcSEcCtD
Desogestrel—Malnutrition—Epirubicin—urinary bladder cancer	0.000204	0.00317	CcSEcCtD
Desogestrel—Diarrhoea—Etoposide—urinary bladder cancer	0.000203	0.00316	CcSEcCtD
Desogestrel—Nausea—Fluorouracil—urinary bladder cancer	0.000203	0.00315	CcSEcCtD
Desogestrel—Eye disorder—Doxorubicin—urinary bladder cancer	0.000203	0.00315	CcSEcCtD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.0002	0.00324	CbGpPWpGaD
Desogestrel—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000196	0.00304	CcSEcCtD
Desogestrel—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—urinary bladder cancer	0.000196	0.00317	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—CXCL8—urinary bladder cancer	0.000196	0.00317	CbGpPWpGaD
Desogestrel—ESR1—Leptin signaling pathway—ERBB2—urinary bladder cancer	0.000195	0.00316	CbGpPWpGaD
Desogestrel—Nausea—Cisplatin—urinary bladder cancer	0.000193	0.00299	CcSEcCtD
Desogestrel—ESR1—Signaling by ERBB4—NCOR1—urinary bladder cancer	0.000192	0.00312	CbGpPWpGaD
Desogestrel—ESR1—ATF-2 transcription factor network—EP300—urinary bladder cancer	0.000192	0.00312	CbGpPWpGaD
Desogestrel—Alopecia—Doxorubicin—urinary bladder cancer	0.000192	0.00298	CcSEcCtD
Desogestrel—ESR1—Regulation of Telomerase—IL2—urinary bladder cancer	0.000191	0.0031	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.00019	0.00309	CbGpPWpGaD
Desogestrel—Mental disorder—Doxorubicin—urinary bladder cancer	0.00019	0.00295	CcSEcCtD
Desogestrel—Vomiting—Etoposide—urinary bladder cancer	0.000189	0.00293	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—ERBB2—urinary bladder cancer	0.000189	0.00306	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000189	0.00306	CbGpPWpGaD
Desogestrel—Malnutrition—Doxorubicin—urinary bladder cancer	0.000189	0.00293	CcSEcCtD
Desogestrel—Rash—Etoposide—urinary bladder cancer	0.000187	0.00291	CcSEcCtD
Desogestrel—Dermatitis—Etoposide—urinary bladder cancer	0.000187	0.00291	CcSEcCtD
Desogestrel—ESR1—AP-1 transcription factor network—IL2—urinary bladder cancer	0.000187	0.00303	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—CCND1—urinary bladder cancer	0.000186	0.00302	CbGpPWpGaD
Desogestrel—Headache—Etoposide—urinary bladder cancer	0.000186	0.00289	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000184	0.00286	CcSEcCtD
Desogestrel—ESR1—AP-1 transcription factor network—CCND1—urinary bladder cancer	0.000182	0.00295	CbGpPWpGaD
Desogestrel—ESR1—Validated nuclear estrogen receptor alpha network—EP300—urinary bladder cancer	0.00018	0.00292	CbGpPWpGaD
Desogestrel—ESR1—LKB1 signaling events—TP53—urinary bladder cancer	0.000177	0.00287	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—MMP9—urinary bladder cancer	0.000177	0.00287	CbGpPWpGaD
Desogestrel—Nausea—Etoposide—urinary bladder cancer	0.000177	0.00274	CcSEcCtD
Desogestrel—Hypertension—Epirubicin—urinary bladder cancer	0.000176	0.00274	CcSEcCtD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—HRAS—urinary bladder cancer	0.000176	0.00285	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—PTEN—urinary bladder cancer	0.000176	0.00285	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000176	0.00285	CbGpPWpGaD
Desogestrel—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000175	0.00271	CcSEcCtD
Desogestrel—Skin disorder—Methotrexate—urinary bladder cancer	0.000173	0.00268	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000173	0.00268	CcSEcCtD
Desogestrel—ESR1—Leptin signaling pathway—CCND1—urinary bladder cancer	0.000172	0.00279	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—EP300—urinary bladder cancer	0.000168	0.00272	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000165	0.00268	CbGpPWpGaD
Desogestrel—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000163	0.00254	CcSEcCtD
Desogestrel—Hypertension—Doxorubicin—urinary bladder cancer	0.000163	0.00253	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000162	0.00263	CbGpPWpGaD
Desogestrel—Skin disorder—Epirubicin—urinary bladder cancer	0.000162	0.00251	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—CDKN1A—urinary bladder cancer	0.000162	0.00262	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—PTEN—urinary bladder cancer	0.000161	0.00261	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000161	0.0026	CbGpPWpGaD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.00016	0.00248	CcSEcCtD
Desogestrel—ESR1—Validated nuclear estrogen receptor alpha network—MYC—urinary bladder cancer	0.000157	0.00254	CbGpPWpGaD
Desogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	0.000157	0.00254	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—FGFR3—urinary bladder cancer	0.000156	0.00252	CbGpPWpGaD
Desogestrel—ESR1—Leptin signaling pathway—SRC—urinary bladder cancer	0.000154	0.0025	CbGpPWpGaD
Desogestrel—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000154	0.00239	CcSEcCtD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—ATM—urinary bladder cancer	0.000153	0.00248	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—CDK4—urinary bladder cancer	0.000153	0.00247	CbGpPWpGaD
Desogestrel—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000151	0.00235	CcSEcCtD
Desogestrel—Skin disorder—Doxorubicin—urinary bladder cancer	0.00015	0.00232	CcSEcCtD
Desogestrel—ESR1—Regulation of Telomerase—MYC—urinary bladder cancer	0.00015	0.00242	CbGpPWpGaD
Desogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	0.000149	0.00242	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—EGFR—urinary bladder cancer	0.000146	0.00237	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—MYC—urinary bladder cancer	0.000146	0.00237	CbGpPWpGaD
Desogestrel—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000146	0.00226	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000144	0.00223	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000144	0.00233	CbGpPWpGaD
Desogestrel—Urticaria—Methotrexate—urinary bladder cancer	0.000141	0.00219	CcSEcCtD
Desogestrel—Abdominal pain—Methotrexate—urinary bladder cancer	0.000141	0.00218	CcSEcCtD
Desogestrel—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000136	0.00211	CcSEcCtD
Desogestrel—PGR—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000136	0.0022	CbGpPWpGaD
Desogestrel—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000133	0.00207	CcSEcCtD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—RB1—urinary bladder cancer	0.000133	0.00215	CbGpPWpGaD
Desogestrel—Urticaria—Epirubicin—urinary bladder cancer	0.000132	0.00205	CcSEcCtD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—CDH1—urinary bladder cancer	0.000132	0.00214	CbGpPWpGaD
Desogestrel—Abdominal pain—Epirubicin—urinary bladder cancer	0.000132	0.00204	CcSEcCtD
Desogestrel—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000131	0.00204	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—EGFR—urinary bladder cancer	0.000131	0.00212	CbGpPWpGaD
Desogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	0.00013	0.00211	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.000127	0.00206	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000126	0.00205	CbGpPWpGaD
Desogestrel—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000126	0.00196	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—KRAS—urinary bladder cancer	0.000124	0.00201	CbGpPWpGaD
Desogestrel—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000123	0.0019	CcSEcCtD
Desogestrel—Urticaria—Doxorubicin—urinary bladder cancer	0.000122	0.0019	CcSEcCtD
Desogestrel—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000122	0.00189	CcSEcCtD
Desogestrel—Diarrhoea—Methotrexate—urinary bladder cancer	0.000122	0.00189	CcSEcCtD
Desogestrel—ESR1—AP-1 transcription factor network—TP53—urinary bladder cancer	0.00012	0.00195	CbGpPWpGaD
Desogestrel—Diarrhoea—Epirubicin—urinary bladder cancer	0.000114	0.00177	CcSEcCtD
Desogestrel—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000114	0.00176	CcSEcCtD
Desogestrel—PGR—Signaling Pathways—HDAC4—urinary bladder cancer	0.000113	0.00184	CbGpPWpGaD
Desogestrel—Vomiting—Methotrexate—urinary bladder cancer	0.000113	0.00176	CcSEcCtD
Desogestrel—Rash—Methotrexate—urinary bladder cancer	0.000112	0.00174	CcSEcCtD
Desogestrel—Dermatitis—Methotrexate—urinary bladder cancer	0.000112	0.00174	CcSEcCtD
Desogestrel—Headache—Methotrexate—urinary bladder cancer	0.000112	0.00173	CcSEcCtD
Desogestrel—ESR1—Signaling by ERBB4—ERBB2—urinary bladder cancer	0.000111	0.0018	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.00011	0.00179	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000109	0.00177	CbGpPWpGaD
Desogestrel—ESR1—Leptin signaling pathway—HRAS—urinary bladder cancer	0.000109	0.00176	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000107	0.00173	CbGpPWpGaD
Desogestrel—Vomiting—Epirubicin—urinary bladder cancer	0.000106	0.00164	CcSEcCtD
Desogestrel—Nausea—Methotrexate—urinary bladder cancer	0.000106	0.00164	CcSEcCtD
Desogestrel—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000105	0.00164	CcSEcCtD
Desogestrel—PGR—Signaling by ERBB4—HRAS—urinary bladder cancer	0.000105	0.0017	CbGpPWpGaD
Desogestrel—Rash—Epirubicin—urinary bladder cancer	0.000105	0.00163	CcSEcCtD
Desogestrel—Dermatitis—Epirubicin—urinary bladder cancer	0.000105	0.00163	CcSEcCtD
Desogestrel—Headache—Epirubicin—urinary bladder cancer	0.000104	0.00162	CcSEcCtD
Desogestrel—ESR1—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000103	0.00167	CbGpPWpGaD
Desogestrel—Nausea—Epirubicin—urinary bladder cancer	9.9e-05	0.00154	CcSEcCtD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	9.85e-05	0.0016	CbGpPWpGaD
Desogestrel—Vomiting—Doxorubicin—urinary bladder cancer	9.8e-05	0.00152	CcSEcCtD
Desogestrel—Rash—Doxorubicin—urinary bladder cancer	9.72e-05	0.00151	CcSEcCtD
Desogestrel—PGR—Generic Transcription Pathway—PPARG—urinary bladder cancer	9.72e-05	0.00158	CbGpPWpGaD
Desogestrel—Dermatitis—Doxorubicin—urinary bladder cancer	9.71e-05	0.00151	CcSEcCtD
Desogestrel—PGR—Gene Expression—SMC1A—urinary bladder cancer	9.7e-05	0.00157	CbGpPWpGaD
Desogestrel—Headache—Doxorubicin—urinary bladder cancer	9.66e-05	0.0015	CcSEcCtD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	9.51e-05	0.00154	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—GLI1—urinary bladder cancer	9.51e-05	0.00154	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—CDKN1A—urinary bladder cancer	9.48e-05	0.00154	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—PTEN—urinary bladder cancer	9.46e-05	0.00153	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—CREBBP—urinary bladder cancer	9.34e-05	0.00151	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	9.24e-05	0.0015	CbGpPWpGaD
Desogestrel—Nausea—Doxorubicin—urinary bladder cancer	9.16e-05	0.00142	CcSEcCtD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	9.07e-05	0.00147	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	9.03e-05	0.00146	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—ESR2—urinary bladder cancer	8.46e-05	0.00137	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	8.16e-05	0.00132	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—NCOR1—urinary bladder cancer	7.96e-05	0.00129	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	7.9e-05	0.00128	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	7.9e-05	0.00128	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	7.88e-05	0.00128	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	7.73e-05	0.00125	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—EGFR—urinary bladder cancer	7.69e-05	0.00125	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	7.51e-05	0.00122	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	7.31e-05	0.00118	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	7.3e-05	0.00118	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—KRAS—urinary bladder cancer	7.26e-05	0.00118	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—HDAC4—urinary bladder cancer	6.66e-05	0.00108	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	6.55e-05	0.00106	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—NCOR1—urinary bladder cancer	6.53e-05	0.00106	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—RBX1—urinary bladder cancer	6.51e-05	0.00106	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	6.49e-05	0.00105	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	6.4e-05	0.00104	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—HRAS—urinary bladder cancer	6.17e-05	0.001	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—ERCC2—urinary bladder cancer	6.14e-05	0.000995	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TSC1—urinary bladder cancer	6.13e-05	0.000993	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	6.1e-05	0.000988	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	6.05e-05	0.00098	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—JAG1—urinary bladder cancer	5.83e-05	0.000945	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—PPARG—urinary bladder cancer	5.7e-05	0.000925	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—SMC1A—urinary bladder cancer	5.7e-05	0.000923	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—GLI1—urinary bladder cancer	5.58e-05	0.000904	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—MYC—urinary bladder cancer	5.54e-05	0.000898	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—CREBBP—urinary bladder cancer	5.48e-05	0.000888	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	5.38e-05	0.000871	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—ESR1—urinary bladder cancer	5.13e-05	0.000831	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—ESR2—urinary bladder cancer	4.96e-05	0.000804	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—S100B—urinary bladder cancer	4.72e-05	0.000765	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—PPARG—urinary bladder cancer	4.68e-05	0.000758	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—CREBBP—urinary bladder cancer	4.5e-05	0.000729	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—NCOR1—urinary bladder cancer	4.25e-05	0.000688	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—NCOR1—urinary bladder cancer	3.83e-05	0.000621	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—RBX1—urinary bladder cancer	3.82e-05	0.00062	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TERT—urinary bladder cancer	3.74e-05	0.000606	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—ERCC2—urinary bladder cancer	3.6e-05	0.000584	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TSC1—urinary bladder cancer	3.59e-05	0.000583	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—FGFR3—urinary bladder cancer	3.43e-05	0.000556	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—JAG1—urinary bladder cancer	3.42e-05	0.000555	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—ESR1—urinary bladder cancer	3.34e-05	0.00054	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—MYC—urinary bladder cancer	3.25e-05	0.000527	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CREBBP—urinary bladder cancer	2.92e-05	0.000474	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—IGF1—urinary bladder cancer	2.89e-05	0.000468	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—S100B—urinary bladder cancer	2.77e-05	0.000449	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—PPARG—urinary bladder cancer	2.75e-05	0.000445	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—MYC—urinary bladder cancer	2.67e-05	0.000432	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—RHOA—urinary bladder cancer	2.64e-05	0.000429	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—CREBBP—urinary bladder cancer	2.64e-05	0.000428	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NCOR1—urinary bladder cancer	2.49e-05	0.000404	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—ERBB2—urinary bladder cancer	2.45e-05	0.000397	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CXCL8—urinary bladder cancer	2.32e-05	0.000376	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—IL2—urinary bladder cancer	2.22e-05	0.00036	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TERT—urinary bladder cancer	2.2e-05	0.000356	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CCND1—urinary bladder cancer	2.16e-05	0.00035	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MMP9—urinary bladder cancer	2.1e-05	0.00034	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CDKN1A—urinary bladder cancer	2.09e-05	0.000339	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PTEN—urinary bladder cancer	2.09e-05	0.000338	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—FGFR3—urinary bladder cancer	2.02e-05	0.000327	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—EP300—urinary bladder cancer	1.99e-05	0.000323	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—SRC—urinary bladder cancer	1.94e-05	0.000314	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MYC—urinary bladder cancer	1.73e-05	0.000281	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CREBBP—urinary bladder cancer	1.72e-05	0.000278	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—EGFR—urinary bladder cancer	1.7e-05	0.000275	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—IGF1—urinary bladder cancer	1.69e-05	0.000275	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—KRAS—urinary bladder cancer	1.6e-05	0.00026	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—MYC—urinary bladder cancer	1.57e-05	0.000254	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—RHOA—urinary bladder cancer	1.55e-05	0.000252	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—ERBB2—urinary bladder cancer	1.44e-05	0.000233	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TP53—urinary bladder cancer	1.42e-05	0.000231	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CXCL8—urinary bladder cancer	1.36e-05	0.000221	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—HRAS—urinary bladder cancer	1.36e-05	0.000221	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—IL2—urinary bladder cancer	1.3e-05	0.000211	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CCND1—urinary bladder cancer	1.27e-05	0.000206	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MMP9—urinary bladder cancer	1.23e-05	0.0002	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.23e-05	0.000199	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PTEN—urinary bladder cancer	1.23e-05	0.000199	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—EP300—urinary bladder cancer	1.17e-05	0.000189	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—SRC—urinary bladder cancer	1.14e-05	0.000184	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MYC—urinary bladder cancer	1.02e-05	0.000165	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—EGFR—urinary bladder cancer	9.96e-06	0.000161	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—KRAS—urinary bladder cancer	9.41e-06	0.000152	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TP53—urinary bladder cancer	8.36e-06	0.000136	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—HRAS—urinary bladder cancer	8e-06	0.00013	CbGpPWpGaD
